Pancreatic cancer halted by virus injection in three patients

(scienceinhand.com)

170 points | by cybermango 3 hours ago ago

15 comments

  • tombert 24 minutes ago ago

    My favorite uncle died from pancreatic cancer when I was a teenager. I remember at the time I quickly looked up the survivability rates of pancreatic cancer and was immediately sad to see it was nearly zero [1].

    For the next few months, there was a roller coaster of hearing about his new treatments, sometimes seeming effective where we would convince ourselves that he's going to get better, only for him to take a turn for the worse. This kept happening until, of course, he died. I was sad he was dead but the combination of the cancer and the chemo seemed really miserable so I was at least happy he wasn't in pain anymore.

    This happened around the time Patrick Swayze died from pancreatic cancer, and a bit before Steve Jobs, and it was at least a little reassuring that this disease didn't spare even obscenely wealthy people. I hope we figure out better treatments for it, and this seems promising.

    [1] At least when caught late, which it often is and was for him.

  • HedonicEscal8r 37 minutes ago ago

    Relevant recent paper from the lead researcher: https://doi.org/10.1158/1535-7163.MCT-25-1231

    Very early results, but it's exciting stuff. I am less confident in this specific trial working out than I am in some therapies in this field making significant progress in the next few years. (As usual, I am reminded how terribly slow research is for people that need treatments now.)

  • dwattttt an hour ago ago

    An excellent source, Kurzgesagt covered the use of virology to cure cancer recently: https://youtu.be/0NY2gAftzJE?si=yeYfT4yc8_ffGmDD

  • epistasis an hour ago ago

    I was trying to figure out what the actual intervention was, and what clinical trial this is from based on the extremely limited information, and have not been able to yet.

    In the mean time, here's 25 clinical trials for oncolytic viral therapies for pancreatic cancer:

    https://clinicaltrials.gov/search?cond=Pancreatic%20Cancer&i...

    And here's a review article on the general concept from the lead physician-researcher in this article:

    https://pmc.ncbi.nlm.nih.gov/articles/PMC6186423/

    Adenoviruses are very easy to make with custom contents, and are used for many many purposes. However they rarely make it all the way to become a therapy in practice.

    It's always fascinating what hits the front page of HN when it comes to bio!

  • DivingForGold 2 hours ago ago
    • HedonicEscal8r an hour ago ago

      A link with no subscription wall: https://archive.ph/2Et0x

    • ksd482 an hour ago ago

      yes! what's with the original link? I thought my internet was down or browser malfunctioned. No response for 20 seconds or so.

      • _Microft an hour ago ago

        I‘m getting 403/forbidden here.

  • cosmotic an hour ago ago

    Is it normal to not report how many people received the treatment and just report the number of successes? Is this better than placebo or doing nothing?

    • goda90 an hour ago ago

      It sounds like it might've been the first three people to receive the treatment at all. 15 more are going to be given higher doses next to hunt for an optimum level.

      I think with trials involving experimental life saving treatment for terminal illnesses, doing things like control groups and placebos isn't considered particularly ethical, since you'd be giving false hope to someone who is knocking on death's door.

    • HedonicEscal8r 33 minutes ago ago

      It's normal for a Phase 1 trial, which evaluates safety and dosing on a small number of participants. If the drug passes, more extensive trials will be done.

    • nutjob2 39 minutes ago ago

      Why test against a placebo when you can test against death?

      Although not 100%, almost all terminal patients will die. If you select your test group well so they are very likely to die, then you improve the information you get from the test, favor the class of patients who are most likely to benefit from the treatment and least likely to be harmed by it overall.

  • phendrenad2 an hour ago ago

    I remember hearing about this way back in 2014. Science moves slowly.

  • bigbuppo 34 minutes ago ago

    Still no cure for... wait, what?